These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 20402561

  • 1. Human CYPs involved in drug metabolism: structures, substrates and binding affinities.
    Lewis DF, Ito Y.
    Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):661-74. PubMed ID: 20402561
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ.
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [Abstract] [Full Text] [Related]

  • 6. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
    Dong D, Wu B.
    Drug Metab Rev; 2012 Feb; 44(1):1-17. PubMed ID: 22242930
    [Abstract] [Full Text] [Related]

  • 7. A role for CYP in the drug-hormone crosstalk of the brain.
    Meyer RP, Gehlhaus M.
    Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):675-87. PubMed ID: 20201748
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cytochrome P450-mediated metabolism in the human gut wall.
    Thelen K, Dressman JB.
    J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
    [Abstract] [Full Text] [Related]

  • 10. In silico predictive metabolism: a structural/electronic filter method.
    Harris DL.
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):43-8. PubMed ID: 14982147
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of density functional theory in drug metabolism studies.
    Rydberg P, Jørgensen FS, Olsen L.
    Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):215-27. PubMed ID: 24295134
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mechanisms and significance of inhibitory drug interactions involving cytochrome P450 enzymes (review).
    Murray M.
    Int J Mol Med; 1999 Mar; 3(3):227-38. PubMed ID: 10028046
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF, Liu JP, Chowbay B.
    Drug Metab Rev; 2009 Mar; 41(2):89-295. PubMed ID: 19514967
    [Abstract] [Full Text] [Related]

  • 20. Mice as clinically relevant models for the study of cytochrome P450-dependent metabolism.
    Muruganandan S, Sinal CJ.
    Clin Pharmacol Ther; 2008 Jun; 83(6):818-28. PubMed ID: 18388875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.